In Collaboration with the Open Estonia Foundation and
the Estonian National Tuberculosis Program
May 18-20, 1999
| 9AM | Welcome
Kai Vink, MD, Manager, Estonian National Tuberculosis Program; Physician, Tartu University Lung Hospital |
| 9:15 | The Legacy of Albert Schweitzer
Michelle Portlock, Director of Programs, Albert Schweitzer Institute for the Humanities, USA |
| 9:30 | Global View of Tuberculosis Epidemiology
John Porter, MD, Public Health Epidemiologist, London School of Hygiene and Tropical Medicine, UK |
| 10:15 | Tuberculosis and the DOTS Experience in
Estonia
Manfrid Danilovits, MD, Estonian National Tuberculosis Program; Head, Tuberculosis Department, Tartu University Lung Hospital |
| 10:45 | Break |
| 11:00 | Tuberculosis and the DOTS Experience in
Lithuania
Edita Davidaviciene, MD, Chief Advisor in Tuberculosis, Ministry of Health Care, Lithuania |
| 11:30 | Discussion |
| 11:45 | Lunch |
| 12:45 | Tuberculosis and the DOTS Experience in
Latvia
Janis Leimanis, MD, Director, State Center for Tuberculosis and Lung Disease, Latvia |
| 1:15 | Discussion |
| 1:30- 3:30 | Panel Discussion
Policies and Practices for Screening, Diagnosis, and Tracking Tuberculosis Estonia: Manfrid Danilovits, MD Latvia: Janis Leimanis, MD Lithuania: Edita Davidaviciene, MD USA: Karen Galanowsky, RN, BSN, MPH, Nurse Consultant, Tuberculosis Control, Department of Health and Senior Services, New Jersey, USA |
| 3:30 | Discussion |
| 9:00 | Current Concepts in Tuberculosis Microbiology
Francis Drobniewski, MD, Public Health Laboratory and Medical Microbiology, King’s College School of Medicine and Dentistry, King’s College Hospital, UK |
| 9:45 | Chemotherapy: Managing the Challenge of
Drug Resistance
Richard Coker, FRCP, Consultant Physician, St. Mary’s Hospital, London, UK |
| 10:30 | Discussion |
| 10:45 | Break |
| 11:00 | The Role of the Tuberculosis Nurse
Karen Galanowsky, RN, BSN, MPH |
| 11:45 | Discussion |
| 12:00 | Lunch |
| 1:00 | The Role of NGOs in Tuberculosis Control:
The MERLIN Experience and the KNVC Experience
Tim Healing, PhD, Epidemiologist, Medical Emergency Relief International (MERLIN), UK Jaap Veen, MD, PhD, Senior Consultant, Tuberculosis, Royal Netherlands Tuberculosis Association (KNCV) |
| 2:00 | Prison Reform: Health and Human Rights
Implications
Tim Harding, MD, Director, University Institute of Forensic Medicine, Switzerland |
| 2:45 | Discussion |
| 3:00 | Break |
| 3:15-4:30 | Panel Discussion
Identification and Management of Tuberculosis in High Risk Populations MERLIN: Tim Healing, PhD Russia: Alex Goldfarb, PhD, Director, Soros/Public Health Research Institute Russian Tuberculosis Project, New York, USA ICRC: Hernan Reyes, MD, Research Scholar, Center for the Study of Society and Medicine, Columbia University, USA KNCV: Jaap Veen, MD, PhD Estonia: Kai Vink, MD |
| 4:30 | Discussion |
| 9:00 | The Special Problem of Tuberculosis in
the Prisons
Hernan Reyes, MD |
| 9:45 | Tuberculosis in Prisons: The Russian Experience
Alex Goldfarb, PhD |
| 10:30 | Break
|
| 10:45-11:45 | Panel Discussion: Tuberculosis in Baltic
Prisons
Estonia: Kai Vink, MD Latvia: Andra Circule, MD, Deputy Director, Clinical Medicine, State Center of Tuberculosis and Lung Diseases Lithuania: Rita Baltusiene, MD, Senior Inspector, Health Care Service, Ministry of Internal Affairs |
| 11:45 | Discussion |
| 12:15 | Lunch |
| 1:15 | Ethical Issues in Public Health and Epidemiology
John Porter, MD |
| 2:00 | NGO Panel Discussion |
| 3:00 | Discussion |
| 3:15 | Break |
| 3:30 | Panel Discussion
What Next in the Baltics? Estonia: Manfrid Danilovits, MD Latvia: Janis Leimanis, MD Lithuania: Edita Davidaviciene, MD Russia: Alex Goldfarb, PhD |
| 4:30 | Discussion |
| 5:00 | Closing Ceremony |